S&P 500   4,286.65 (+0.10%)
DOW   33,749.28 (-0.04%)
QQQ   355.52 (+0.25%)
AAPL   183.41 (+1.36%)
MSFT   336.02 (+0.18%)
META   272.09 (-0.19%)
GOOGL   125.06 (+0.31%)
AMZN   124.26 (+0.01%)
TSLA   219.06 (+2.38%)
NVDA   393.30 (+0.01%)
NIO   7.69 (+1.72%)
BABA   84.00 (-0.32%)
AMD   117.25 (-0.52%)
T   15.32 (+0.72%)
F   12.64 (+2.02%)
MU   68.75 (-0.61%)
CGC   0.82 (-0.32%)
GE   105.34 (-0.43%)
DIS   90.42 (-0.39%)
AMC   4.63 (+1.76%)
PFE   38.51 (+0.39%)
PYPL   64.35 (+0.61%)
NFLX   402.81 (+0.58%)
S&P 500   4,286.65 (+0.10%)
DOW   33,749.28 (-0.04%)
QQQ   355.52 (+0.25%)
AAPL   183.41 (+1.36%)
MSFT   336.02 (+0.18%)
META   272.09 (-0.19%)
GOOGL   125.06 (+0.31%)
AMZN   124.26 (+0.01%)
TSLA   219.06 (+2.38%)
NVDA   393.30 (+0.01%)
NIO   7.69 (+1.72%)
BABA   84.00 (-0.32%)
AMD   117.25 (-0.52%)
T   15.32 (+0.72%)
F   12.64 (+2.02%)
MU   68.75 (-0.61%)
CGC   0.82 (-0.32%)
GE   105.34 (-0.43%)
DIS   90.42 (-0.39%)
AMC   4.63 (+1.76%)
PFE   38.51 (+0.39%)
PYPL   64.35 (+0.61%)
NFLX   402.81 (+0.58%)
S&P 500   4,286.65 (+0.10%)
DOW   33,749.28 (-0.04%)
QQQ   355.52 (+0.25%)
AAPL   183.41 (+1.36%)
MSFT   336.02 (+0.18%)
META   272.09 (-0.19%)
GOOGL   125.06 (+0.31%)
AMZN   124.26 (+0.01%)
TSLA   219.06 (+2.38%)
NVDA   393.30 (+0.01%)
NIO   7.69 (+1.72%)
BABA   84.00 (-0.32%)
AMD   117.25 (-0.52%)
T   15.32 (+0.72%)
F   12.64 (+2.02%)
MU   68.75 (-0.61%)
CGC   0.82 (-0.32%)
GE   105.34 (-0.43%)
DIS   90.42 (-0.39%)
AMC   4.63 (+1.76%)
PFE   38.51 (+0.39%)
PYPL   64.35 (+0.61%)
NFLX   402.81 (+0.58%)
S&P 500   4,286.65 (+0.10%)
DOW   33,749.28 (-0.04%)
QQQ   355.52 (+0.25%)
AAPL   183.41 (+1.36%)
MSFT   336.02 (+0.18%)
META   272.09 (-0.19%)
GOOGL   125.06 (+0.31%)
AMZN   124.26 (+0.01%)
TSLA   219.06 (+2.38%)
NVDA   393.30 (+0.01%)
NIO   7.69 (+1.72%)
BABA   84.00 (-0.32%)
AMD   117.25 (-0.52%)
T   15.32 (+0.72%)
F   12.64 (+2.02%)
MU   68.75 (-0.61%)
CGC   0.82 (-0.32%)
GE   105.34 (-0.43%)
DIS   90.42 (-0.39%)
AMC   4.63 (+1.76%)
PFE   38.51 (+0.39%)
PYPL   64.35 (+0.61%)
NFLX   402.81 (+0.58%)
NASDAQ:EPIX

ESSA Pharma (EPIX) Earnings Date, Estimates & Call Transcripts

$3.09
+0.04 (+1.31%)
(As of 09:30 AM ET)
Compare
Today's Range
$3.09
▼
$3.09
50-Day Range
$2.60
▼
$3.15
52-Week Range
$1.40
▼
$5.38
Volume
1,923 shs
Average Volume
151,609 shs
Market Capitalization
$136.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Aug. 3Estimated
Actual EPS
(May. 9)
-$0.16 Beat By $0.04
Consensus EPS
(May. 9)
-$0.20
Last Year's Q2 EPS
(5/10/2022)
-$0.25
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

EPIX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EPIX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ESSA Pharma Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20234($0.44)($0.18)($0.27)
Q2 20234($0.45)($0.19)($0.28)
Q3 20234($0.46)($0.19)($0.28)
Q4 20234($0.50)($0.16)($0.29)
FY 202316($1.85)($0.72)($1.11)
Q1 20241($0.25)($0.25)($0.25)
Q2 20241($0.28)($0.28)($0.28)
Q3 20241($0.31)($0.31)($0.31)
Q4 20241($0.31)($0.31)($0.31)
FY 20244($1.15)($1.15)($1.15)

EPIX Earnings Date and Information

ESSA Pharma last announced its quarterly earnings results on May 9th, 2023. The reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.04. ESSA Pharma has generated ($0.65) earnings per share over the last year (($0.65) diluted earnings per share). Earnings for ESSA Pharma are expected to decrease in the coming year, from ($0.75) to ($1.00) per share. ESSA Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off prior year's report dates.

ESSA Pharma Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/3/2023
(Estimated)		        
5/9/2023Q2 2023($0.20)($0.16)+$0.04($0.16)
2/7/2023Q1 2023($0.24)($0.15)+$0.09($0.15)
12/13/2022Q4 2022($0.28)($0.14)+$0.14($0.14)
8/4/2022Q3 2022($0.27)($0.20)+$0.07($0.20)
5/10/2022Q2 2022($0.25)($0.25)($0.25)
2/3/2022Q1 2022($0.23)($0.21)+$0.02($0.21)
11/18/20219/30/2021($0.23)($0.20)+$0.03($0.20)
8/15/20216/30/2021($0.26)($0.21)+$0.05($0.21)
5/6/20213/31/2021($0.21)($0.36)($0.15)($0.36)  
2/11/202112/31/2020($0.17)($0.20)($0.03)($0.20)
12/15/20209/30/2020($0.20)($0.17)+$0.03($0.17)
8/6/2020Q3 2020($0.29)($0.24)+$0.05($0.24)
5/7/20203/31/2020($0.22)($0.45)($0.23)($0.45)
2/13/2020Q1($0.1750)($0.22)($0.0450)($0.22)
12/19/2019Q4 2019($0.15)($0.06)+$0.09($0.19)
8/14/2019Q3 2019($0.54)($0.52)+$0.02($0.52)
5/10/2019Q2 2019($0.44)($0.54)($0.10)($0.54)
2/7/2019Q1 2019($0.42)($0.42)($0.42)
12/13/20189/30/2018($0.43)($0.39)+$0.04($0.39)
8/14/2018Q3 2018($0.74)($0.50)+$0.24($0.50)
5/14/2018Q2 2018($0.40)($0.83)($0.43)($0.83)
2/13/2018Q1 2018($0.07)($0.07)($0.07)
12/11/2017Q4 2017($0.09)($0.09)($0.11)
8/14/2017Q3 2017($0.17)($0.16)+$0.01($0.44)
5/15/2017Q2 2017($0.11)($0.26)($0.15)($0.26)
2/13/2017Q1 2017$0.05+$0.05$0.05
12/14/2016Q4 2016($0.19)($0.19)($0.23)
8/12/2016Q3 2016($0.13)($0.13)($0.13)
5/13/2016Q2 2016($0.20)($0.20)($0.36)
2/12/2016Q1 2016($0.18)($0.18)($0.18)
12/14/2015Q4 2015$0.02+$0.02$0.02
8/17/2015Q3 2015($0.28)($0.28)($0.28)












ESSA Pharma Earnings - Frequently Asked Questions

When is ESSA Pharma's earnings date?

ESSA Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off last year's report dates. Learn more on EPIX's earnings history.

Did ESSA Pharma beat their earnings estimates last quarter?

In the previous quarter, ESSA Pharma (NASDAQ:EPIX) reported ($0.16) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.20) by $0.04. Learn more on analysts' earnings estimate vs. EPIX's actual earnings.

How much profit does ESSA Pharma generate each year?

ESSA Pharma (NASDAQ:EPIX) has a recorded net income of -$35.10 million. EPIX has generated -$0.65 earnings per share over the last four quarters.

What is ESSA Pharma's EPS forecast for next year?

ESSA Pharma's earnings are expected to decrease from ($0.75) per share to ($1.00) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:EPIX) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -